Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Ur Energy stock logo

1. Ur Energy NYSEAMERICAN:URG

$1.22 -0.03 (-2.40%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$1.22 0.00 (0.00%)
As of 07/31/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization
$484.81 million
Consensus Rating
Buy
Consensus Price Target
$2.36 (+93.3% Upside)
Volume
7.20 million shares
Average Volume
6.33 million shares
Today's Range
$1.20
▼
$1.27
iBio stock logo

2. iBio NASDAQ:IBIO

$1.40 +0.01 (+0.72%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.40 +0.01 (+0.36%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization
$69.55 million
Consensus Rating
Buy
Consensus Price Target
$5.00 (+257.1% Upside)
Volume
728,592 shares
Average Volume
791,969 shares
Today's Range
$1.34
▼
$1.47
Larimar Therapeutics stock logo

3. Larimar Therapeutics NASDAQ:LRMR

$3.82 -0.01 (-0.26%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.84 +0.02 (+0.52%)
As of 07/31/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Larimar Therapeutics, Inc, a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. More about Larimar Therapeutics

Market Capitalization
$396.83 million
Consensus Rating
Buy
Consensus Price Target
$12.71 (+232.8% Upside)
Volume
1.06 million shares
Average Volume
1.65 million shares
Today's Range
$3.72
▼
$3.86
Inventiva stock logo

4. Inventiva NASDAQ:IVA

$4.48 -0.14 (-3.03%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$4.47 -0.01 (-0.20%)
As of 07/31/2026 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inventiva SA, a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. More about Inventiva

Market Capitalization
$930.53 million
Consensus Rating
Buy
Consensus Price Target
$16.56 (+269.5% Upside)
Volume
1.35 million shares
Average Volume
1.19 million shares
Today's Range
$4.34
▼
$4.63
Uranium Royalty stock logo

5. Uranium Royalty NASDAQ:UROY

$3.40 -0.02 (-0.58%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.36 -0.04 (-1.32%)
As of 07/31/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Uranium Royalty Corp. operates as a pure-play uranium royalty company. It acquires, accumulates, and manages a portfolio of geographically diversified uranium interests. More about Uranium Royalty

Market Capitalization
$499.21 million
P/E Ratio
170.09
Consensus Rating
Buy
Consensus Price Target
$4.13 (+21.3% Upside)
Volume
5.10 million shares
Average Volume
3.06 million shares
Aquestive Therapeutics stock logo

6. Aquestive Therapeutics NASDAQ:AQST

$3.69 -0.03 (-0.81%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.68 0.00 (-0.14%)
As of 07/31/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aquestive Therapeutics, Inc operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. More about Aquestive Therapeutics

Market Capitalization
$463.60 million
Consensus Rating
Buy
Consensus Price Target
$8.50 (+130.4% Upside)
Volume
1.79 million shares
Average Volume
1.76 million shares
Today's Range
$3.61
▼
$3.78
Inhibikase Therapeutics stock logo

7. Inhibikase Therapeutics NASDAQ:IKT

$2.18 -0.10 (-4.39%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$2.17 -0.01 (-0.23%)
As of 07/31/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization
$287.83 million
Consensus Rating
Buy
Consensus Price Target
$5.40 (+147.7% Upside)
Volume
369,546 shares
Average Volume
994,381 shares
Today's Range
$2.13
▼
$2.29
Palisade Bio stock logo

8. Palisade Bio NASDAQ:PALI

$1.90 -0.07 (-3.32%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.88 -0.02 (-0.79%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization
$328.93 million
Consensus Rating
Buy
Consensus Price Target
$9.00 (+374.9% Upside)
Volume
1.85 million shares
Average Volume
2.82 million shares
Today's Range
$1.86
▼
$1.95
Inuvo stock logo

9. Inuvo NYSEAMERICAN:INUV

$0.92 -0.05 (-4.66%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$0.92 +0.00 (+0.43%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). More about Inuvo

Market Capitalization
$13.64 million
Consensus Rating
Buy
Consensus Price Target
$7.33 (+697.1% Upside)
Volume
197,479 shares
Average Volume
335,039 shares
Today's Range
$0.90
▼
$0.98
Lexeo Therapeutics stock logo

10. Lexeo Therapeutics NASDAQ:LXEO

$4.13 -0.22 (-5.06%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.94 -0.20 (-4.72%)
As of 07/31/2026 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo Therapeutics

Market Capitalization
$324.30 million
Consensus Rating
Buy
Consensus Price Target
$18.75 (+354.0% Upside)
Volume
713,512 shares
Average Volume
918,682 shares
Today's Range
$4.07
▼
$4.38
Stereotaxis stock logo

11. Stereotaxis NYSEAMERICAN:STXS

$1.26 -0.07 (-5.26%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$1.29 +0.03 (+2.06%)
As of 07/31/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization
$123.40 million
Consensus Rating
Buy
Consensus Price Target
$3.88 (+207.5% Upside)
Volume
719,183 shares
Average Volume
1.35 million shares
Today's Range
$1.24
▼
$1.35
Satellogic stock logo

12. Satellogic NASDAQ:SATL

$3.58 +0.09 (+2.58%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.60 +0.02 (+0.50%)
As of 07/31/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Satellogic Inc operates as an integrated geospatial company in the Asia Pacific, North America, and internationally. It engages in tasking satellites with monitoring assets and keeping up with their changing reality for government and commercial customers; control satellites on top of specific areas of interest for governments; and sale and support satellites. More about Satellogic

Market Capitalization
$530.71 million
Consensus Rating
Buy
Consensus Price Target
$9.10 (+154.2% Upside)
Volume
3.58 million shares
Average Volume
4.35 million shares
Today's Range
$3.48
▼
$3.72
Adagene stock logo

13. Adagene NASDAQ:ADAG

$3.75 +0.02 (+0.54%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.74 -0.01 (-0.27%)
As of 07/31/2026 05:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Adagene Inc, a clinical stage biotechnology company, engages in the research, development, and production of monoclonal antibody drugs for cancers. More about Adagene

Market Capitalization
$177.70 million
Consensus Rating
Buy
Consensus Price Target
$8.00 (+113.3% Upside)
Volume
152,404 shares
Average Volume
259,280 shares
Today's Range
$3.71
▼
$4.01
Perspective Therapeutics stock logo

14. Perspective Therapeutics NYSEAMERICAN:CATX

$2.91 -0.08 (-2.68%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$2.92 +0.00 (+0.17%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$331.87 million
Consensus Rating
Buy
Consensus Price Target
$12.63 (+333.8% Upside)
Volume
827,579 shares
Average Volume
1.48 million shares
Today's Range
$2.83
▼
$3.04
Trilogy Metals stock logo

15. Trilogy Metals NYSEAMERICAN:TMQ

$3.13 -0.05 (-1.57%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$3.10 -0.03 (-0.96%)
As of 07/31/2026 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Trilogy Metals Inc, a base metals exploration company, engages in the exploration and development of mineral properties in the United States. More about Trilogy Metals

Market Capitalization
$540.23 million
Consensus Rating
Buy
Consensus Price Target
$7.75 (+147.6% Upside)
Volume
1.11 million shares
Average Volume
1.46 million shares
Today's Range
$3.08
▼
$3.20
Peraso stock logo

16. Peraso NASDAQ:PRSO

$0.65 +0.01 (+0.78%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$0.64 -0.01 (-1.08%)
As of 07/31/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Peraso Inc, a fabless semiconductor company, develops, markets, and sells semiconductor devices and modules. The company's products include millimeter wavelength (mmWave) ICs, including baseband IC, various mmWave radio frequency, integrated circuits, as well as associated antenna technology; and mmWave antenna modules. More about Peraso

Market Capitalization
$9.55 million
Consensus Rating
Buy
Consensus Price Target
$3.00 (+363.0% Upside)
Volume
262,642 shares
Average Volume
313,334 shares
Today's Range
$0.61
▼
$0.68
CytomX Therapeutics stock logo

17. CytomX Therapeutics NASDAQ:CTMX

$3.10 -0.18 (-5.49%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.10 +0.00 (+0.16%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX Therapeutics

Market Capitalization
$527.58 million
Consensus Rating
Buy
Consensus Price Target
$12.10 (+290.3% Upside)
Volume
3.50 million shares
Average Volume
3.03 million shares
Today's Range
$3.10
▼
$3.28
Americas Gold and Silver stock logo

18. Americas Gold and Silver NYSEAMERICAN:USAS

$3.82 -0.12 (-3.05%)
Closing price 07/31/2026 04:10 PM Eastern
Extended Trading
$3.83 +0.01 (+0.37%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Americas Gold and Silver Corporation engages in the acquisition, evaluation, exploration, development, and operation of mineral properties. More about Americas Gold and Silver

Market Capitalization
$1.29 billion
Consensus Rating
Buy
Consensus Price Target
$9.75 (+155.2% Upside)
Volume
3.96 million shares
Average Volume
3.65 million shares
Today's Range
$3.69
▼
$3.89
Microbot Medical stock logo

19. Microbot Medical NASDAQ:MBOT

$1.72 -0.02 (-1.15%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.70 -0.01 (-0.87%)
As of 07/31/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. More about Microbot Medical

Market Capitalization
$115.52 million
Consensus Rating
Buy
Consensus Price Target
$6.63 (+285.2% Upside)
Volume
309,786 shares
Average Volume
529,463 shares
Today's Range
$1.68
▼
$1.76
Grab stock logo

20. Grab NASDAQ:GRAB

$3.50 +0.10 (+2.94%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.50 +0.00 (+0.14%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Grab Holdings Limited engages in the provision of superapps in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. More about Grab

Market Capitalization
$14.34 billion
P/E Ratio
350.35
Consensus Rating
Moderate Buy
Consensus Price Target
$6.01 (+71.6% Upside)
Volume
42.12 million shares
Average Volume
42.63 million shares
Ovid Therapeutics stock logo

21. Ovid Therapeutics NASDAQ:OVID

$2.22 -0.15 (-6.33%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$2.22 -0.01 (-0.23%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$414.34 million
Consensus Rating
Moderate Buy
Consensus Price Target
$5.13 (+130.9% Upside)
Volume
1.74 million shares
Average Volume
1.56 million shares
Today's Range
$2.20
▼
$2.36
Exagen stock logo

22. Exagen NASDAQ:XGN

$4.53 -0.14 (-3.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$4.53 0.00 (0.00%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Exagen Inc develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). More about Exagen

Market Capitalization
$109.44 million
Consensus Rating
Moderate Buy
Consensus Price Target
$9.00 (+98.7% Upside)
Volume
105,874 shares
Average Volume
225,495 shares
Today's Range
$4.38
▼
$4.72
Context Therapeutics stock logo

23. Context Therapeutics NASDAQ:CNTX

$0.60 -0.01 (-1.30%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$0.59 -0.01 (-1.74%)
As of 07/31/2026 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$55.07 million
Consensus Rating
Moderate Buy
Consensus Price Target
$6.17 (+928.8% Upside)
Volume
961,658 shares
Average Volume
2.30 million shares
Today's Range
$0.58
▼
$0.61
Autolus Therapeutics stock logo

24. Autolus Therapeutics NASDAQ:AUTL

$1.49 -0.04 (-2.61%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.50 +0.01 (+0.34%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization
$396.57 million
Consensus Rating
Moderate Buy
Consensus Price Target
$8.75 (+487.2% Upside)
Volume
815,255 shares
Average Volume
1.08 million shares
Today's Range
$1.47
▼
$1.55
InflaRx stock logo

25. InflaRx NASDAQ:IFRX

$1.70 -0.02 (-1.16%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$1.70 0.00 (0.00%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. More about InflaRx

Market Capitalization
$122.90 million
Consensus Rating
Moderate Buy
Consensus Price Target
$7.00 (+311.8% Upside)
Volume
583,912 shares
Average Volume
948,056 shares
Today's Range
$1.64
▼
$1.76

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas